Prognostic value of left atrial size in chronic kidney disease

Mark Y Chan1, Hwee-Bee Wong, Hean-Yee Ong

  • 1The Heart Institute, National University Hospital, Singapore.

Insights

In patients with chronic kidney disease (CKD), increased left atrial (LA) diameter is a strong predictor of cardiovascular disease (CVD) mortality, independent of stress imaging results. This simple measurement can aid risk stratification.

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Imaging

Background:

  • Patients with chronic kidney disease (CKD) face elevated cardiovascular disease (CVD) risk.
  • Stress imaging is used for CVD risk estimation in CKD patients, but the added value of combined imaging is unclear.

Purpose of the Study:

  • To evaluate the incremental value of combinatorial cardiac imaging in predicting CVD mortality in patients with CKD.
  • To determine if transthoracic echocardiography and stress single-photon emission computed tomography (SPECT) improve risk prediction in this population.

Main Methods:

  • 200 CKD patients (creatinine clearance <60 mL/min) without prior coronary heart disease underwent echocardiography and stress SPECT.
  • Follow-up duration was 3.7 years, during which cardiovascular disease (CVD) mortality was recorded.

Main Results:

  • 25 CVD deaths occurred during follow-up.
  • Univariate analysis showed older age, abnormal SPECT, and increased indexed left atrial (LA) diameter predicted CVD mortality.
  • Multivariable analysis revealed indexed LA diameter >24 mm/m² independently predicted CVD mortality (HR 2.75), while abnormal SPECT did not.

Conclusions:

  • Indexed LA diameter is an independent predictor of CVD mortality in CKD patients.
  • This simple echocardiographic measurement offers prognostic value beyond stress SPECT.
  • Indexed LA diameter should be considered a prognostic tool for cardiovascular risk in CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...